Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.1164 USD -0.07% Market Closed
Market Cap: 102.3m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Journey Medical Corp
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Journey Medical Corp
Income from Continuing Operations Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Journey Medical Corp
NASDAQ:DERM
Income from Continuing Operations
-$3.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$14.8B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
$4.3B
CAGR 3-Years
-40%
CAGR 5-Years
4%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
5%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
12%

See Also

What is Journey Medical Corp's Income from Continuing Operations?
Income from Continuing Operations
-3.9m USD

Based on the financial report for Dec 31, 2023, Journey Medical Corp's Income from Continuing Operations amounts to -3.9m USD.

What is Journey Medical Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
87%

Over the last year, the Income from Continuing Operations growth was 87%.

Back to Top